Replies to post #236852 on Biotech Values

[vinmantoo]

ABT at all-time high. The company's 2020 performance and 2021 guidance are simply astonishing.

ABT expects $6.5-7B of 2021 COVID-19 diagnostic revenue

Their dividend is pretty low, as it is about 1/3 the dividend ABBV gives. Do you think they will be raising the dividend given how well they are doing?